Sunday, March 23, 2008
The Management of Clostridium difficile Infection: Antibiotics, Probiotics and Other Strategies
The Management of Clostridium difficile Infection: Antibiotics, Probiotics and Other Strategies
J Chemother. 2008 Feb
Senok AC, Rotimi VO.
Clostridium difficile-associated disease remains an important nosocomial infection associated with significant morbidity and mortality. In recent years, there has been an upward trend in the incidence of this condition with continuing high rates of recurrent disease with available treatment regimens. In this article, we review the current literature on the management of C. difficile-associated disease (CDAD). The potential role for alternative therapeutic options for the treatment of CDAD, including the use of bacteriotherapy in the form of probiotics, immunotherapy and ion-exchange resins as well as new drugs under investigation is explored.
The evidence indicates a need for innovative approaches to the management of this condition. The combined use of antibiotic therapy and replacement of gut microbiota using probiotics remains promising and we suggest a multi-pronged approach in the management of this challenging infection.
Journal of Chemotherapy
J Chemother. 2008 Feb
Senok AC, Rotimi VO.
Clostridium difficile-associated disease remains an important nosocomial infection associated with significant morbidity and mortality. In recent years, there has been an upward trend in the incidence of this condition with continuing high rates of recurrent disease with available treatment regimens. In this article, we review the current literature on the management of C. difficile-associated disease (CDAD). The potential role for alternative therapeutic options for the treatment of CDAD, including the use of bacteriotherapy in the form of probiotics, immunotherapy and ion-exchange resins as well as new drugs under investigation is explored.
The evidence indicates a need for innovative approaches to the management of this condition. The combined use of antibiotic therapy and replacement of gut microbiota using probiotics remains promising and we suggest a multi-pronged approach in the management of this challenging infection.
Journal of Chemotherapy
Labels: antibiotics, bacteriotherapy, Clostridium difficile Infection, gut microbiota, immunotherapy, morbidity, mortality, propbiotics
# posted by Pat O'Connor @ 12:31 AM 
